EPCAM and non-small cell lung carcinoma: In the present study, we evaluated for the first time MCT4 expression in CTC fractions isolated by a size- based EpCAM independent technology (Parsortix) from early stage NSCLC patients using a highly sensitive and specific RT-qPCR assay.